Termination of Manufacturing Agreement. As of the Effective Date the Manufacturing Agreement is hereby terminated. The parties agree to cancel any further liabilities or obligations set forth in the Manufacturing Agreement.
Termination of Manufacturing Agreement. Notwithstanding anything to the contrary in the Manufacturing Agreement, NuVasive and Osiris agree that:
(a) Section 7.1 of the Manufacturing Agreement shall be deleted in its entirety and inserting in its place the following. “This Agreement shall commence on the Effective Date and remain in effect until the fifteenth day following the execution by NuVasive and Osiris of this Amendment (the “Termination Date”) and immediately following the Termination Date, Osiris shall cease all manufacturing operations with respect to the Product except as set forth in this Agreement as amended by the Third Amendment.”
(b) NuVasive and Osiris shall use commercially reasonable efforts to obtain the consent of AlloSource to terminate that certain Amended and Restated Tissue Procurement Processing and Supply Agreement by and between Osiris and AlloSource, dated February 1, 2008 (the “AlloSource Supply Agreement”). In the event that AlloSource does not agree to terminate the AlloSource Supply Agreement, NuVasive agrees to assume the AlloSource Supply Agreement.
(c) In the event that AlloSource requests Product to be shipped in freezers designated to be assets of NuVasive, NuVasive hereby authorizes Osiris to ship such Product in such freezers to AlloSource.
Termination of Manufacturing Agreement. If the Manufacturing Agreement is terminated, this Distribution and License Agreement shall also terminate in its entirety as of the effective termination date applicable to the Manufacturing Agreement, subject to Xxxxxx’x inventory sell-off rights set forth in Section 14.8.
Termination of Manufacturing Agreement. This Agreement shall terminate automatically upon the termination of the Manufacturing Agreement if such termination occurs prior to receipt of the approval for marketing and sale of Compound MS-325 and/or its corresponding Licensed Products in the United States and if such termination is a result of MKG’s breach of its obligations thereunder.
Termination of Manufacturing Agreement. Buyer shall have duly executed and delivered to Seller a termination of the Manufacturing Agreement (the "Termination"). Such Termination shall provide that all provisions of the Manufacturing Agreement shall be null and void. Prior to such Termination, the parties shall agree on the amount of all payments due Buyer from Seller for the period up to the Closing, which shall include without limitation, accounts receivable, volume payments, and raw material adjustments (collectively the "Adjustment Payment").
Termination of Manufacturing Agreement. Effective immediately upon the Termination Date, the Parties agree that the Manufacturing Agreement will be and hereby is canceled and terminated, and shall be of no further force and effect and the rights and obligations of each Party thereunder shall terminate; provided, however, that the specific provisions of the Manufacturing Agreement set forth in Section 21.4 thereof and the rights and obligations contained therein shall survive such termination and remain binding upon each Party, as applicable.
Termination of Manufacturing Agreement. In the event a Party is in default of the Manufacturing Agreement and the non-defaulting Party terminates the Manufacturing Agreement in accordance with the terms thereof, the non-defaulting Party shall have the option for a period of thirty (30) days after such termination of the Manufacturing Agreement at its sole option to terminate this Agreement which shall be effective immediately upon sending written notice to the defaulting Party.
Termination of Manufacturing Agreement. As of the date that this Letter Agreement is fully executed by Cardinal and Ligand (the “Effective Date”) the Manufacturing Agreement and the Quality Agreements shall be deemed terminated and of no further force or effect, including without limitation, the termination of any and all provisions in the Manufacturing Agreement which were expressly designated to survive termination, provided that, Sections 4.8 – 4.12, 9.2 and 9.4 and Articles 11 and 16 (the “Surviving Provisions”) shall remain in full force and effect. In addition, all open purchase orders under the Manufacturing Agreement are deemed cancelled and of no further force or effect. Notwithstanding the foregoing, the parties desire for Cardinal to continue to provide certain ongoing stability services, including active reference standards, analytical assays and related program support, which are associated with the current validation and commercial batches of AVINZA®, as referenced in Section 2.1 of the Manufacturing Agreement and as performed by Cardinal pursuant to quotation [***]; quotation [***]; and one quotation as yet to be agreed by the parties (altogether, the “AVINZA® Stability Services”).
Termination of Manufacturing Agreement. Subject to the terms, conditions and exceptions set forth herein, including, without limitation, the provisions of Section 4 below, Lucent and Pliant agree that the Manufacturing Agreement and any and all amendments, modifications and revisions to the Manufacturing Agreement and the PiPON Product Letter are hereby terminated. Lucent and Pliant agree that Lucent is under no further obligation to purchase Material (as that term is defined in Section 2.0 of the Manufacturing Agreement) from Pliant or to make any deficiency payments to Pliant under Section 7.0 or any other provision of the Manufacturing Agreement.
Termination of Manufacturing Agreement. Learning Curve ----------------------------------------- shall cause the Manufacturing Agreement to be terminated at or prior to the Learning Curve Effective Time in a manner that, to the reasonable satisfaction of RCE, results in neither Learning Curve nor any of its Subsidiaries having any obligations or Liabilities under the Manufacturing Agreement after the Learning Curve Effective Time.
